In Brief: Astra Merck

Astra Merck: Nancy Wysenski to VP-sales and Barry Greene to VP-marketing and customer services, filling roles vacated by VP-Sales and Marketing Matthew Emmens. Emmens was named acting CEO Jan. 17, replacing Wayne Yetter, who departed to lead Novartis' U.S. pharmaceuticals business ("The Pink Sheet" Feb. 3, T&G-1). Wysenski was executive director of field sales at Astra Merck; Greene had worked on process design for Astra Merck's sales and marketing organization as an associate partner with Andersen Consulting. Astra Merck also announces the promotions of VP-Drug Development Irwin Scher to chief medical officer and senior VP-drug development; VP-Portfolio Management Dave Brennan to senior VP-business operations; and Rob Cohen, VP-information technology, to chief information officer...